202 related articles for article (PubMed ID: 25560781)
41. Evaluation of Salivary Transcriptome Markers for the Early Detection of Oral Squamous Cell Cancer in a Prospective Blinded Trial.
Martin JL; Gottehrer N; Zalesin H; Hoff PT; Shaw M; Clarkson JH; Haan P; Vartanian M; McLeod T; Swanick SM
Compend Contin Educ Dent; 2015 May; 36(5):365-73. PubMed ID: 26053640
[TBL] [Abstract][Full Text] [Related]
42. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
43. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
[TBL] [Abstract][Full Text] [Related]
44. Proinflammatory cytokines as serum biomarker in oral carcinoma-A prospective multi-biomarker approach.
Schiegnitz E; Kämmerer PW; Schön H; Blatt S; Berres M; Sagheb K; Al-Nawas B
J Oral Pathol Med; 2018 Mar; 47(3):268-274. PubMed ID: 29272054
[TBL] [Abstract][Full Text] [Related]
45. Prevalidation of salivary biomarkers for oral cancer detection.
Elashoff D; Zhou H; Reiss J; Wang J; Xiao H; Henson B; Hu S; Arellano M; Sinha U; Le A; Messadi D; Wang M; Nabili V; Lingen M; Morris D; Randolph T; Feng Z; Akin D; Kastratovic DA; Chia D; Abemayor E; Wong DT
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):664-72. PubMed ID: 22301830
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of synuclein-γ levels by novel monoclonal antibody in saliva and cancer tissues from oral squamous cell carcinoma patients.
Wang K; Shen Y; Xu J; Li Z; Liu Y; Yu C; Peng L; Zheng J; Zeng Y
Neoplasma; 2020 May; 67(3):707-713. PubMed ID: 32202903
[TBL] [Abstract][Full Text] [Related]
47. CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.
Martín-Ezquerra G; Salgado R; Toll A; Baró T; Mojal S; Yébenes M; Garcia-Muret MP; Solé F; Quitllet FA; Espinet B; Pujol RM
Histol Histopathol; 2011 Jan; 26(1):71-7. PubMed ID: 21117028
[TBL] [Abstract][Full Text] [Related]
48. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
Brailo V; Vucićević-Boras V; Cekić-Arambasin A; Alajbeg IZ; Milenović A; Lukac J
Oral Oncol; 2006 Apr; 42(4):370-3. PubMed ID: 16324876
[TBL] [Abstract][Full Text] [Related]
49. Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer.
Brailo V; Vucicevic-Boras V; Lukac J; Biocina-Lukenda D; Zilic-Alajbeg I; Milenovic A; Balija M
Med Oral Patol Oral Cir Bucal; 2012 Jan; 17(1):e10-5. PubMed ID: 21743397
[TBL] [Abstract][Full Text] [Related]
50. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
[TBL] [Abstract][Full Text] [Related]
51. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
52. Salivary transcriptome biomarkers in oral squamous cell cancer detection.
Brinkmann O; Wong DT
Adv Clin Chem; 2011; 55():21-34. PubMed ID: 22126022
[TBL] [Abstract][Full Text] [Related]
53. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma.
Ajona D; Pajares MJ; Chiara MD; Rodrigo JP; Jantus-Lewintre E; Camps C; Suarez C; Bagán JV; Montuenga LM; Pio R
Oral Dis; 2015 Oct; 21(7):899-904. PubMed ID: 26258989
[TBL] [Abstract][Full Text] [Related]
54. Genetic Abnormalities in Oral Leukoplakia and Oral Cancer Progression.
Kil TJ; Kim HS; Kim HJ; Nam W; Cha IH
Asian Pac J Cancer Prev; 2016; 17(6):3001-6. PubMed ID: 27356725
[TBL] [Abstract][Full Text] [Related]
55. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
56. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
[TBL] [Abstract][Full Text] [Related]
57. A non-invasive study to estimate and compare salivary sialic acid level as tumor marker in patients with pre-cancer and oral cancer.
Jacob TV; Ramesh M; Murali S; Ramesh K; Sanjay PR; Abraham P
J Cancer Res Ther; 2016; 12(2):634-9. PubMed ID: 27461623
[TBL] [Abstract][Full Text] [Related]
58. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva.
Arellano-Garcia ME; Hu S; Wang J; Henson B; Zhou H; Chia D; Wong DT
Oral Dis; 2008 Nov; 14(8):705-12. PubMed ID: 19193200
[TBL] [Abstract][Full Text] [Related]
59. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
60. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
